GlobalData’s “Medical Equipment Monthly Deals Analysis: September 2015 – M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed […]
November 2015 Life Science Industry Research Reports
EpiCast Report: Hepatocellular Carcinoma – Epidemiology Forecast to 2024
Hepatocellular carcinoma (HCC) is a common type of primary liver cancer that arises from the hepatocytes in the liver. HCC is classified by various staging systems such as the Barcelona Clinic Liver Cancer (BCLC) stage and Child Pugh stages. The […]
EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2024
OA is a degenerative disease of the entire joint, which involves the cartilage, joint lining, ligaments, and underlying bone. OA is the most common form of joint disease. The most affected joints are the knee, hip, hand, and spine. The […]
EpiCast Report: Dry Eye Syndrome – Epidemiology Forecast to 2024
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. It results in symptoms of discomfort such as visual disturbance and tear […]
Global Antibody Partnering 2010-2015: Deal trends, players and financials
Summary The Global Antibody Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Description Benefits Global Antibody Partnering 2010-2015 provides the reader with the following […]
Global Licensing Terms & Agreements in Pharma, Biotech & Diagnostics 2011-2015
Summary The Global Licensing Terms & Agreements in Pharma, Biotech & Diagnostics 2011-2015 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies. Description Benefits Global Licensing Terms […]